CRS-100

CRS-100 · Anza Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CRS-100, covering 2008-04-24 to 2008-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases [Phase 1]